NCT07074002 Proof of Concept Study on BP1.4979 Effect on Essential Tremor Status RECRUITING Phase PHASE2
NCT07047404 Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation Status RECRUITING Phase PHASE2
NCT05953389 Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05240560 Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke Status TERMINATED Phase PHASE2
NCT03424824 Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment Status COMPLETED Phase PHASE2
NCT03345953 Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome Status TERMINATED Phase PHASE2
NCT03152123 Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users Status COMPLETED Phase PHASE1
NCT02978651 Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness Status WITHDRAWN Phase PHASE3
NCT02929342 Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02800083 A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment Status WITHDRAWN Phase PHASE2
NCT02739568 Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA Status COMPLETED Phase PHASE3
NCT02611687 Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period Status COMPLETED Phase PHASE3
NCT01965301 First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375 Status TERMINATED Phase PHASE1
NCT01948011 Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules Status COMPLETED Phase PHASE1
NCT01800045 Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) Status COMPLETED Phase PHASE3
NCT01789398 Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV) Status COMPLETED Phase PHASE3
NCT01638403 Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy. Status COMPLETED Phase PHASE3
NCT01620554 Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA) Status COMPLETED Phase PHASE2